Home
About
Overview
Sharing Data
ORCID
Help
History (1)
S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway. Int J Oncol. 2013 Mar; 42(3):1001-10.
View in:
PubMed
subject areas
Animals
Calgranulin B
Carcinoma, Hepatocellular
Cell Line, Tumor
Cell Proliferation
Cell Transformation, Neoplastic
Enzyme Inhibitors
Extracellular Signal-Regulated MAP Kinases
Female
Flavonoids
Hep G2 Cells
Humans
Imidazoles
Liver Neoplasms
MAP Kinase Signaling System
Mice
Mice, Nude
Mitogen-Activated Protein Kinases
Neoplasm Invasiveness
Neoplasm Transplantation
p38 Mitogen-Activated Protein Kinases
Phosphorylation
Protein Kinase Inhibitors
Pyridines
Random Allocation
Tetrazolium Salts
Thiazoles
Xenograft Model Antitumor Assays
authors with profiles
Tong-Chuan He